Showing results (21-30 of 153) with videos related to
Sort By:
Pageof 16
Journal of Medical Screening|October 18, 2008
Early reporting for cancer screening trialsStuart G Baker, Barnett S Kramer, Philip C ProrokThe International Journal of Biostatistics|June 21, 2011
Clarifying the role of principal stratification in the paired availability designStuart G Baker, Karen S Lindeman, Barnett S KramerStatistics in Medicine|August 5, 2015
Latent class instrumental variables: a clinical and biostatistical perspectiveStuart G Baker, Barnett S Kramer, Karen S LindemanDiscovery Medicine|April 3, 2012
Biomarkers, subgroup evaluation, and clinical trial designStuart G Baker, Barnett S Kramer, Daniel J Sargent, et al.Journal of the Royal Statistical Society. Series A, (Statistics in Society)|January 14, 2010
Using relative utility curves to evaluate risk predictionStuart G Baker, Nancy R Cook, Andrew Vickers, et al.BMC Medical Research Methodology|April 12, 2003
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screeningStuart G Baker, Diane Erwin, Barnett S Kramer, et al.Biostatistics (Oxford, England)|June 1, 2005
Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariatesStuart G Baker, Garrett M Fitzmaurice, Laurence S Freedman, et al.Biostatistics (Oxford, England)|February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention TrialStuart G Baker, Amy K Darke, Paul Pinsky, et al.Clinical Trials (London, England)|March 17, 2006
Evaluating markers for the early detection of cancer: overview of study designs and methodsStuart G Baker, Barnett S Kramer, Martin McIntosh, et al.Annals of Internal Medicine|April 21, 2010
Cumulative incidence of false-positive test results in lung cancer screening: a randomized trialJennifer M Croswell, Stuart G Baker, Pamela M Marcus, et al.Pageof 16